BioCryst Pharmaceuticals
BCRX
#4543
Rank
โ‚น221.63 B
Marketcap
โ‚น872.22
Share price
0.33%
Change (1 day)
15.55%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2025 (TTM): โ‚น23.96 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น0.87 Billion. , an increase over its 2024 earnings that were of -โ‚น8.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น25.37 B-407.51%
2024 -โ‚น8.26 Billion-61.56%
2023 -โ‚น21.48 Billion-7.43%
2022 -โ‚น23.2 Billion34.42%
2021 -โ‚น17.26 Billion-0.55%
2020 -โ‚น17.36 Billion67.88%
2019 -โ‚น10.34 Billion7.55%
2018 -โ‚น9.61 Billion53.92%
2017 -โ‚น6.25 Billion19.29%
2016 -โ‚น5.24 Billion28.19%
2015 -โ‚น4.09 Billion-4.8%
2014 -โ‚น4.29 Billion50.09%
2013 -โ‚น2.86 Billion-23.29%
2012 -โ‚น3.73 Billion-26.19%
2011 -โ‚น5.05 Billion54.78%
2010 -โ‚น3.27 Billion150.1%
2009 -โ‚น1.31 Billion-49.43%
2008 -โ‚น2.58 Billion14.07%
2007 -โ‚น2.27 Billion-49.31%
2006 -โ‚น4.46 Billion72.87%
2005 -โ‚น2.58 Billion22.08%
2004 -โ‚น2.12 Billion75.3%
2003 -โ‚น1.21 Billion-25.36%
2002 -โ‚น1.62 Billion225.05%
2001 -โ‚น0.5 Billion-56.6%
2000 -โ‚น1.15 Billion50.63%
1999 -โ‚น0.76 Billion38.05%
1998 -โ‚น0.56 Billion-52.46%
1997 -โ‚น1.16 Billion58.44%
1996 -โ‚น0.74 Billion-14.44%
1995 -โ‚น0.86 Billion28.57%
1994 -โ‚น0.67 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚น929.83 B 3,563.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น939.20 B 3,600.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-โ‚น66.65 Billion-362.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น7.96 B-68.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น44.10 B 73.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น27.28 Billion-207.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚น0.78 Billion-103.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น2.36 Billion-109.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น15.68 B-38.18%๐Ÿ‡บ๐Ÿ‡ธ USA